Skip to content

Clinical trials

Insulin Resistance trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Country / region: Canada Clear all

197 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20025
20032
20043
20056
20064
20076
20085
20096
20108
201110
201216
20139
20148
201514
201614
201712
20188
201912
20204
20215
20227
20237
20247
20259
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed135
Unknown status24
Recruiting14
Withdrawn8
Terminated6
Active, not recruiting6
Not yet recruiting2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut de Recherches Cliniques de Montreal17
Laval University17
McGill University Health Centre/Research Institute of the McGill University Health Centre15
University of Toronto14
University Health Network, Toronto11
University of Manitoba7
John Sievenpiper6
McGill University6
Population Health Research Institute6
Université de Sherbrooke5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance197
Diabetes Mellitus43
Obesity39
Diabetes Mellitus, Type 235
Diabetes Mellitus, Type 129
Metabolic Syndrome24
Overweight22
Hypoglycemia19
Prediabetic State19
Cardiovascular Diseases15

Trials

Showing 51 to 75 of 197. Each trial links to its page on Pharma Observatory.

97 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.